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Temperate bacteriophages effect chromosomal evolution of their bacterial hosts, mediating rearrangements
and the acquisition of novel genes from other taxa. Although the Haemophilus influenzae genome shows evidence
of past phage-mediated lateral transfer, the phages presumed responsible have not been identified. To date, six
different H. influenzae phages are known; of these, only the HP1/S2 group, which lyosogenizes exclusively Rd
strains (which were originally encapsulated serotype d), is well characterized. Phages in this group are
genetically very similar, with a highly conserved set of genes. Because the majority of H. influenzae strains are
nonencapsulated (nontypeable), it is important to characterize phages infecting this larger, genetically more
diverse group of respiratory pathogens. We have identified and sequenced HP2, a bacteriophage of nontypeable
H. influenzae. Although related to the fully sequenced HP1 (and even more so to the partially sequenced S2) and
similar in genetic organization, HP2 has a few novel genes and differs in host range; HP2 will not infect or
lysogenize Rd strains. Genomic comparisons between HP1/S2 and HP2 suggest recent divergence, with new
genes completely replacing old ones at certain loci. Sequence comparisons suggest that H. influenzae phages
evolve by recombinational exchange of genes with each other, with cryptic prophages, and with the host
chromosome.
The host range of temperate bacteriophages is determined
by multiple factors. Since phages require cellular components
for replication, they become specialized to a compatible bac-
terial species. Within a host species, divergent restriction sys-
tems and surface receptors create barriers to interstrain trans-
mission. Phages may overcome host range barriers by evolving
DNA methylation systems (24) or by varying the structure of
tail fiber proteins used for adsorption (31). The temperate
bacteriophages of nonencapsulated (e.g., nontypeable) Hae-
mophilus influenzae (NTHI) face adaptive challenges because
of the unusually high genetic diversity of these bacteria (43).
Here we describe a new temperate prophage, HP2, found in
NTHI strains that are associated with unusual virulence.
Although six H. influenzae phages are described in the liter-
ature (HP1, S2A, B, C, N3, and flu), only HP1 and three types
of S2 have been described in detail (4, 19, 21, 30, 43). Both
HP1 and S2 infect H. influenzae Rd strains (4, 19), which were
originally derived from an encapsulated serotype d (Sd) strain,
but do not possess the genes for capsular biosynthesis (2, 15).
We have discovered a new member of the HP1/S2 family that
occurs as a prophage in the chromosome of strain R2866, a
nontypeable invasive H. influenzae isolate (26).
DNA sequence analysis of HP1 and S2 types A, B, and C
shows that these phages are closely related. Closer examina-
tion shows that type C is probably the original HP1 (37). Type
A has many similarities to type C, but differences in the struc-
tures of the early promoter region suggest a different regula-
tion of the lytic-versus-lysogeny decision. The type B variety
appears to be a chimera between types A and C. The original
host of the HP1/S2 bacteriophages is unknown, but UV-in-
duced mixed-culture filtrates lysogenized an Rd derivative. All
HP1 and S2 type phages have similar morphologies when
viewed with an electron microscope. The N3 bacteriophage has
a similar head structure, but a longer tail. The N3 phage is
found only in particular NTHI strains, and on restriction anal-
ysis, it has a pattern distinct from HP1 (43). No other infor-
mation or sequence data on N3 are available. flu is an incom-
plete phage found in the Rd KW20 genome and has genes
homologous to ones in HP1 (21).
HP1, with its 32-kb genome, belongs to the family of bacte-
riophages represented by Escherichia coli P2. Historically HP1
was used to elucidate the mechanism of natural transformation
in H. influenzae (6, 27, 33, 41, 42). HP1 is a temperate phage
capable of either a lytic infection or lysogeny of the host. The
promoters controlling the lysis-versus-lysogeny decision are lo-
cated near the 5 end of the genome (9): one leftward and two
rightward promoters transcribe cI and cox, which have genetic
and functional homology to transcriptional regulators in
lambda. In vitro HP1 cI, cox, and int function similarly to their
counterparts in lambda. In HP1, the majority of the genes
downstream from these regulators appear to encode proteins
that are part of phage structure and assembly apparatus. The
function of these downstream genes is inferred on the basis of
homology to genes in other phages.
The S2 phages also appear capable of a temperate life cycle
in Rd hosts. The 5 5.6 kb of this phage was sequenced for
comparison to HP1 (36). Major sequence differences between
S2 and HP1 are interspersed with regions of high homology.
While investigating a previously described invasive NTHI
strain (26, 46), we found a prophage whose range was limited
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to this strain and a few other NTHI strains. To elucidate
whether the phage provided clues to the unusual virulence of
this strain, we sequenced its chromosome and found a close
relationship to HP1 and S2. H. influenzae Sd strains and Rd
derivatives are not lysogenic for HP2; however, HP2 can lyso-
genize a phage-deleted form of its original host.
MATERIALS AND METHODS
Bacteria and media. The bacteria used in this study are described in Table 1.
Strain R2866, originally described as Int1, is a biotype V, nontypeable H. influ-
enzae strain isolated from the blood of an immunocompetent child with signs of
meningitis (26). This strain is serum resistant and harbors a 54-kb conjugal
plasmid that encodes a -lactamase. sBHI broth was made up of brain heart
infusion (BHI) medium (Difco, Becton Dickinson, Sparks, Md.) supplemented
with 10 g (each) of hemin-HCl (Sigma, St. Louis, Mo.), L-histidine (Sigma), and
-NAD (Sigma) per ml. The heme solution was prepared by mixing 100 mg of
hemin-HCl and L-histidine in 100 ml of 50°C water, to which 0.4 ml of 10 N
NaOH (Sigma) is added. The solution was filter sterilized with a 0.22-m-pore-
diameter filter and stored at 4°C in a lightproof container for no more than 3
weeks. -NAD was dissolved in water to a concentration of 1 mg/ml, filter
sterilized, and stored at 4°C. One volume of these solutions was aseptically added
to 100 volumes of BHI broth prior to use. Chocolate agar was prepared as
described by Difco with GC Media base. To avoid contamination with gram-
positive organisms, bacitracin was added to all solid H. influenzae growth media
at a final concentration of 500 U/liter (10 g/ml), and all incubations were done
at 37°C in air. Luria-Bertani (LB) agar and broth (Difco) were used for E. coli.
Phage induction. To induce bacteriophage from the lysogens, a 100-ml sBHI
culture was grown with shaking at 1,200 rpm at 37°C to an A600 of 0.15 to 0.2.
Mitomycin C (Sigma) was added to a final concentration of 35 ng/ml, and the
culture was shaken at 50 to 100 rpm. Bacterial replication continued to an A600
of 1.0, after which the optical density decreased, presumably due to phage-
mediated lysis. When the optical density reached its minimum, generally 4 to 6 h
after the addition of mitomycin C, the cells were pelleted by centrifugation at
20,000  g for 15 min at 4°C in a Beckman J21 centrifuge. The supernatant was
removed, and the centrifugation step was repeated to remove residual intact
cells. The resulting supernatant was passed through a 0.22-m-pore-diameter
TABLE 1. Bacterial strains used in this work
Strain Relevant characteristics Source or reference
E. coli DH5 Cloning host Gibco BRL
H. influenzae
Rd Derivative of Garf Sd 2
Rd KW20 Genome sequence 45
R3153 Rd strain for plaquing (BC200) 3
Rd Mc1 Minicell producing strain 32
R3152 HP1 lysogen 6
R2866 HP2 lysogen 26
R539 Type a (Pittman 610) ATCC 9006
R538 Type b (Pittman 641) ATCC 9795
R540 Type c (Pittman 624) ATCC 9007
R541 Type d (Pittman 611) ATCC 9008
R542 Type e (Pittman 595) ATCC 8142
R543 Type f (Pittman 644) ATCC 9833
Other Haemophilus sp. strains
H. somnus ATCC 43625
R1966 H. parainfluenzae ATCC 33392
R3358 H. aegyptius ATCC 11116
R1968 H. aphrophilus ATCC 33389
R1969 H. paraphrophilus ATCC 29241
R1970 H. haemolyticus ATCC 33390
R1985 H. parahaemolyticus ATCC 29237
R1972 H. haemoglobinophilus ATCC 19416
R1973 H. segnis ATCC 33393
R1974 H. parasuis ATCC 19417
R1976 H. equigenitalis ATCC 35865
R1985 H. parahaemolyticus ATCC 10014
R1986 H. paracuniculus ATCC 29986
R1989 H. paragallinarum ATCC 29545
R1990 H. avium ATCC 29546
R1992 H. ducreyi ATCC 33940
R1975 H. pleuropneumoniae ATCC 27088
Other gram-negative spp.
N. gonorrhoeae Joan Knapp, Centers for Disease Control
and Prevention, Atlanta, Ga.
P. multocida ATCC 8369
P. aeruginosa ATCC 27853
H. influenzae strain constructs
R3420 R2866 with HP2 deleted, Ribr This study
R3422 R2866 with HP2 deleted, Cmr This study
R3403 R3152 with first 5 kb of HP2 (HP1/HP2P) This study
R3404 R2866 with first 5 kb of HP1 (HP2/HP1P) This study
R3435 R2866 with TSTE insertion in HP2 dam, Ribr This study
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filter, after which chloroform was added (20 l/100 ml). Phage-containing su-
pernatant was stored at 4°C until further use. To concentrate the bacteriophage
particles, the supernatant was centrifuged in 33-ml ultracentrifuge tubes at
40,000 rpm in a Ti 50.2 rotor for 3 h at 15°C. The resulting pellet was resus-
pended in a minimal amount of phosphate-buffered saline (PBS) overnight at
4°C with gentle shaking.
Plaque assay. Bacteria were grown in sBHI broth to an A600 of 0.2 and then
mixed with 1:5 to 1:100,000 dilutions (in PBS) of culture supernatant prepared as
described above for phage induction. Soft agar consisted of 5 ml of 0.7% sBHI
agar layered on a standard sBHI agar plate. The target strain was grown in sBHI
broth to an A600 of 0.2 and diluted 1:100 in the same medium, an aliquot was
added to the phage preparation, and 0.1 ml was spread over the surface of the
soft agar. After overnight incubation at 37°C, clear plaques were counted (44).
Electron microscopy. Concentrated bacteriophage stocks were stained in ura-
nyl acetate (5) and visualized by T.P. with a JEOL 1200 EX transmission electron
microscope at the Electron Microscopy Core at the University of Missouri—
Columbia.
DNA isolation. To purify phage for sequencing, 200 l of resuspended phage
pellet in sBHI was treated with 0.1 U of DNase I (Gibco-BRL, Rockville, Md.)
for 30 min at 37°C. After DNase treatment, the phage preparation was extracted
with an equal volume of Tris-saturated phenol (pH 8.0)–chloroform–isoamyl
alcohol in proportions of 25:24:1. The aqueous layer was removed, and the
extraction was repeated with an equal volume of fresh phenol solution. The DNA
was precipitated from the aqueous layer by addition of 1/10 volume of 3 M
sodium acetate (pH 4.0) and 2.5 volumes of absolute ethanol at 20°C and
concentrated by centrifugation, and the pellet was washed with 1 ml of 70%
ethanol at room temperature. After centrifugation at 12,000  g for 15 min at
4°C, the ethanol solution was aspirated, and the pellet was allowed to air dry
before resuspension in 50 l of water or PBS.
Sequencing. Sequencing was performed at the University of Washington Ge-
nome Center as described by Stover et al. (40). Phage DNA was cloned into
pUC19, and the insert was sequenced with primers synthesized by that unit. The
data set involved 462 dye-terminator and 123 dye-primer sequencing reads,
sampled at random from the phage genome. The average number of q20 bases
per read was 408. A q20 base is a base call with an estimated error rate of 1% as
calculated by the PHRED base-calling software (11, 12). The redundancy of the
data, in terms of q20 bases, was 7.6. Low-quality regions were resolved by a
combination of manual and automated finishing procedures as described previ-
ously (17). An estimate of the number of remaining errors in the sequence based
on quality scores was calculated with the phrap assembly software (16), which can
be accessed at http://www.phrap.org. The expected number of residual errors in
this 31.5-kb sequence was 0.16. In our experience, sequence with less than one
predicted error usually has no errors. In addition, both strands of the first 10 kb
of HP2 from attP to orf10 were independently sequenced at the University of
Missouri DNA Core by using the same vector and method, and no differences
were observed.
DNA analysis. Open reading frames (ORFs) were identified using the ORF
finder function in the OMIGA software program (Oxford Molecular). The ri-
bosome binding sites in the HP2 ORFs were compared to the previously deter-
mined HP1 and S2 sequences to verify the most likely start codons. Similarity
plots were obtained with the GCG software program available (Wisconsin Ge-
nome Center).
H. influenzae transformation. H. influenzae was transformed by the M-IV
technique (39). Gel-purified PCR fragments or linearized plasmid DNA was
added to competent H. influenzae, and dilutions were plated on chocolate agar
plates containing either ribostamycin (Sigma) at 30 g/ml (for the TSTE cas-
sette) or chloramphenicol at 5 g/ml (for the cat cassette).
Southern analysis. DNA was transferred from agarose gels to nylon mem-
branes (Osmonics, Inc., Minnetonka, Minn.) by using a vacuum-assisted appa-
ratus (Hoeffer Scientific). Agarose gels were depurinated in 0.25 M HCl for 1 h,
followed by denaturation in 1.5 M NaCl containing 0.5 M NaOH for 30 min (29).
Transfers were performed for 3 h in 20 SSC (1 SSC is 0.15 M NaCl plus
0.015 M sodium citrate), after which the membrane was treated with UV light to
cross-link the DNA. Chemiluminescent detection was performed with which
digoxigenin-labeled oligonucleotide probes or double-stranded PCR products as
recommended by the manufacturers (Roche, Indianapolis, Ind.).
PCR amplification. Table 2 lists the primers used for PCR amplification of
selected portions of the HP1 and HP2 prophages. The locations of these primers
on the HP2 genome map are shown in Fig. 1. For PCR amplification of frag-
ments shorter than 2 kb, standard Taq polymerase was used according to the
manufacturer’s instructions (Perkin-Elmer, Boston, Mass.). An Eppendorf ther-
mocycler (model, Mastercycler) was set to run 35 cycles of 94°C for 30 s, 55°C for
30 s, and 72°C for 30 s in that order. Occasional primer sets required adjustment
of the annealing temperature. For larger products of up to 18 kb, the long-range
PCR kit from Roche (GeneAmp XL) was used.
Construction of an HP2 host. The plasmids used in the HP2 host construct are
described in Table 3. Using PCR primers 1 and 2, a 1.7-kb fragment of HP2 DNA
containing int and attP was amplified and ligated to pTrcHisB restricted with
BamHI and XhoI (pBJ102). PCR primers 3 and 4 were used to amplify a 2.0-kb
downstream portion of the HP2 prophage that was subsequently ligated into
pBJ102 digested with BglII and EcoRI (pBJ102.2). A BamHI-restricted TSTE
cassette was ligated into BglII-digested pBJ102.2 to create pBJ102.3. The TSTE
cassette contains the aph(3)I gene flanked by H. influenzae-specific uptake
(hUS) sequences (34). The TSTE cassette confers ribostamycin resistance to
H. influenzae and kanamycin resistance to E. coli. Plasmid pBJ102.3 was digested
with BamHI and EcoRI and used to transform competent H. influenzae strain
R2866 with selection for ribostamycin resistance. Of 12 ribostamycin-resistant
transformants, 2 were shown to be devoid of most of the prophage genome by
Southern blotting and to lack phage production after mitomycin C treatment, as
assessed by electron microscope observation and infection assays (data not
shown). One such mutant was designated R3420 (Fig. 2). R3422 is a derivative
of R3420 with a chloramphenicol acetyltransferase cassette replacing the
aph(3)I gene, inserted between two HincII sites.
Construction of hybrid lysogens. Early experiments indicated that HP2 would
not form plaques on any of the Rd derivatives or strain R3420, its original host,
from which HP2 was isolated. To identify the genetic regions determining the
host range of HP2, we created hybrid lysogens of HP1 and HP2 (Fig. 2). This was
accomplished by first cloning a 7.5-kb HindIII prophage fragment containing the
HP2 immunity genes from strain R2866 into the HindIII site of pUC18. This
plasmid, designated pBJ100.1, contains a portion of a threonine synthetase gene
and a BamHI site in an intergenic region 5 to the prophage. After cloning TSTE
into this BamHI site, the plasmid (pBJ100.2) was linearized and transformed into
competent R3152 selecting for ribostamycin resistance. One transformant (des-
ignated HP1/HP2P [strain R3403]) of 12 examined acquired the HP2 immunity
region as indicated by PCR. The chromosomal DNA of another transformant
that retained the HP1 immunity region was digested and transformed into
R2866. One transformant of the 12 that acquired HP1 immunity region was
designated HP2/HP1P (strain R3404) (Table 1). To verify the construction of the
hybrid phages, we performed a Southern analysis of BglI-restricted DNA har-
vested from phage preparations of HP1, HP2, HP1/HP2P (R3403), and HP2/
HP1P (R3404) by using a digoxigenin-labeled PCR product generated from
primers 5 and 6 as a probe. HP2 contains a 2.0-kb fragment, while in HP1, the
hybridizing fragment is smaller, as predicted. HP1/HP2P has the 2-kb BglI frag-
ment, while HP2/HP1P has the smaller fragment.
TABLE 2. Oligonucleotide primers used in this work
Primer Sequencea Target/use
1 GAGACGGATCCGTTTGCACAACTACGGGCTTA Cloning of the 5 terminus of HP2 upstream of attP (BamHI)
2 GAGACCGCTCGAGCGGATGGCTTGCGGAAGTTTATG Cloning of the 5 terminus of HP2 upstream of integrase (XhoI)
3 GAGAGGAAGATCTCCCGGTCAAAATCTACCCGAAA 3 terminus of HP2 (BglII)
4 GAGACGGAATTCCGCTTTAGTTTGCTCCGCAACC Cloning of the 3 terminus of HP2 at position 29,742 (EcoRI)
5 GCTGCTCTACCGACTGAGCTA Creation of a PCR probe to the early genes of HP1  HP2
6 AGACGGTGAGGCACGTTTAG Creation of a PCR probe to the early genes of HP1  HP2
7 AAGGGGGAAATAATGGCAAC Cloning of HP2 genes in the pR promoter group
8 AAAGGATTGTTATTGCCCC Cloning of HP2 genes in the pR promoter group
a Sequences run 5 to 3, with restriction sites listed in target use underlined.
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Construction of marked HP2 derivative. To assess the ability of HP2 to
lysogenize a host, we created a prophage mutant in R2866 with the TSTE
cassette marking the phage. The insertion of TSTE into the phage dam gene
resulted in no detectable phenotypic changes in growth rate or phage yields. This
insertion was created by first cloning a portion of the prophage with primers 7
and 8 to amplify a 7-kb segment of the phage containing most of the genes driven
by the pR promoters. This PCR product was digested with HindIII and EcoRI
and ligated into pKS to create pBJ105. pBJ105 was digested with NcoI, which
cuts this plasmid uniquely in the dam gene, and was treated with T4 polymerase.
A BamHI-digested, T4 polymerase-treated TSTE cassette was ligated to this
plasmid to yield pBJ105.2. This plasmid was digested with HindIII and EcoRI
and transformed into R2866 with subsequent selection of ribostamycin-resistant
colonies. Southern analysis of chromosomal DNA and phage extract DNA from
eight colonies revealed one mutant, R3435, which contained the TSTE cassette
in the dam gene of the HP2 prophage (data not shown).
Nucleotide sequence accession number. The HP2 sequence has been depos-
ited in GenBank under accession no. AY027935.
RESULTS AND DISCUSSION
The HP2 genome. The HP2 chromosome consists of 31,508
bp, similar to the size of S2 phage types A and B based on
restriction mapping (28). The molar percentage of adenine and
thymidine (AT%) in the HP2 chromosome is 60.04%, a
value similar to that in the Rd KW20 chromosome (61.86%)
(15). The frequency of the triplet base combinations, coding
and noncoding, in HP2 is also very similar to that in Rd KW20
(data not shown), which suggests that this bacteriophage was
not recently introduced into H. influenzae.
The organization of the HP2 genome is shown in Fig. 1;
cohesive ends are similar to those in HP1 (data not shown).
HP2 appears to contain five transcriptional units, with the
control of each of these units directing or repressing bacterio-
FIG. 1. Genetic map of HP2. Straight arrows indicate the approximate position of each ORF. The scale is in kilobases. Bent arrows indicate
the locations of RNA polymerase promoter elements. Ball-and-stick figures indicate the locations of transcription terminators. Arrows above the
map indicate locations of primers used in this work. The length of the HP2 chromosome is 31,508 bp. Primer 1 is homologous to coordinates 3088
to 3072 of the H. influenzae Rd KW20 genome (section 9 of 163).
TABLE 3. Plasmids used in this study
Plasmid Relevant characteristics Source or reference
pKS Cloning vector Stratagene
pUC18 Cloning vector 47
pTrcHisB Vector for production of His-tagged fusion Invitrogen
pUC4DEcat cat gene used in H. influenzae cloning Chlorr 7
pTSTE apH(3)I flanked by H. influenzae uptake sequences in pBR322; Ribr 34
pBJ100.1 HindIII fragment of R2866 chromosome from position 139332 (in HI0123) to
bp 5194 of the prophage in pUC18
This study
pBJ100.2 pBJ100.1 with TSTE located in BamHI site upstream of the prophage attP site This study
pBJ102 TrcHisB containing a 1.7-kb fragment from the 5 end of the HP2 prophage This study
pBJ102.2 pPBJ102 containing a 2.0-kb fragment of the 3 end of the HP2 prophage 3
to the early fragment
This study
pBJ102.3 apH(3)I inserted between the two prophage fragments in pBJ102.2 This study
pBJ102.4 dCAT inserted between the two prophage fragments in pBJ102.1 This study
pBJ105 pKS containing the HindIII-EcoRI fragment of the HP2 prophage located in
the pR transcription frame
This study
pBJ105.2 pBJ105 with TSTE located in the NcoI site in dam This study
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phage replication. As in HP1, the pR1, pR2, and pL1 promoters
of HP2 adjoin the early regulatory elements. Flanking these
promoters are elements believed to control the lysis-versus-
lysogeny decision (13). If the products of the pL1 promoter
dominate, lysogeny is maintained, repressing all other bacte-
riophage gene expression. If the pR1 and pR2 promoters are
activated, the lytic cycle will ensue. Products of the pR1- and
pR2-activated transcript should control bacteriophage DNA
replication and presumably activation of the downstream genes
through hypothetical promoter elements between orf16 and
orf17. Genes responsible for bacteriophage particle production
and host lysis reside in these diverging transcripts, one of which
contains orf15 and orf16, while the other contains orf17
through orf35. Many of the ORFs in the latter transcript show
homology to structural proteins of P2 and other phages. As in
HP1, orf14 appears to have its own promoter and terminator.
The role of this gene in HP1 and HP2 is unknown. It is unique
in being the only gene in these phages that appears capable of
independent control.
HP2 regulatory elements. The pR and pL promoters con-
trolling the lysis-versus-lysogeny decision differ among HP1,
HP2, and S2 phages. Analysis of these regions indicates that
both of the pR promoters are maintained in HP2, whereas the
pR1 promoter, and its corresponding cI-coded protein binding
site, is missing from S2 (Fig. 3). The nucleotide sequences of
these promoter regions differ at numerous sites: areas that are
conserved are the 10, 35, and cI- and cox-coded protein
binding sites. This suggests HP2 has retained a functional con-
trol unit for phage induction and repression. As in S2, the cox
homologue of HP1 is absent. Whereas the orf2 genes of HP2
and S2 are similar to cox (see below), the finding of intact Cox
protein binding sites suggests that a Cox-like protein performs
this function. The spacing between the 10 and 35 sites of
pR1 in HP2 is 16 or 17 bp, depending on which thymidine
residue is considered the start of the 10 site. The pR1 pro-
moter may be functionally redundant, since S2 lacks pR1, yet
appears fully capable of controlling lysis versus lysogeny in
H. influenzae Rd strains.
Outside of this promoter region, the sequence of HP2 is very
similar to that of S2, while within the promoter region, HP2 is
more homologous to HP1 (Fig. 4). All three phages have
identical sequences at the 10 and 35 sites of pL, the left-
ward promoter, and the sequence between these promoters,
suggesting a close relationship between S2 and HP2. It seems
unlikely that HP2 is a simple recombinant of S2 and HP1,
because certain regions in each phage have a different nucle-
otide sequence.
Regulation of lysis. Since the structures of the promoter
elements and repressors controlling the lysis-versus-lysogeny
decision differ between HP1 and HP2 (see above), we sought
to determine if the HP2 immunity region could mediate mit-
omycin C induction in an Rd host. We generated a hybrid
FIG. 2. Genetic maps of strains used in this work. Straight arrows indicate ORFs and their orientation. Bent arrows indicate the locations of
the transcription promoters. Diagonal striped boxes indicate the boundaries of host DNA. DNA originating from the HP1 or HP2 host is shown
in dark or light gray, respectively. The TSTE box indicates the location of the antibiotic cassette used for genetic manipulations. These maps are
not to scale but approximate the total numbers of genes and their relative sizes.
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phage in which the first 5 kb of HP2 from attP to orf7 was
replaced with the homologous region of HP1 (HP2/HP1P
[strain R3404]). Conversely, we constructed an HP1 lysogen in
which the first 5 kb was replaced with the homologous region
of HP2 (HP1/HP2P [strain R3403]). After mitomycin C induc-
tion, the A600 of the R3403 culture decreased in a manner
similar to that of strain R3152 (Fig. 5). This indicates that the
promoter region of HP2 is compatible with mitomycin induc-
tion and is capable of inducing phage replication and lysis in an
H. influenzae Rd derivative. Strain R3404 grew only on solid
media, precluding examination of the effect of mitomycin C.
Plaque formation. Strain R3152 typically yielded between
3.6  104 and 4.2  105 PFU/ml of culture supernatant with
mitomycin C induction when it formed plaques on strain
BC200. Similar titers were obtained when HP1 formed plaques
on strains Rd and Rd Mc1. We did not observe HP1 plaques
with any of the encapsulated H. influenzae strains, any of the
other Haemophilus species, or Pasteurella multocida, Neisseria
gonorrhoeae, or Pseudomonas aeruginosa. Similarly HP2 would
not form plaques on any Haemophilus species listed in Table 1
or on P. multocida, N. gonorrhoeae, or P. aeruginosa.
At high phage concentrations, both HP1 and HP2 com-
pletely cleared lawns of strains Rd and R3422, respectively
(Table 4). Plaques on a lawn of Rd became visible when HP1
was diluted 10,000-fold. The plaques produced by HP1 ranged
from 1.5 to 2.5 mm in size and were usually turbid. Gradual
dilution and infection of R3422 with HP2 resulted in lawns that
gradually became more turbid as the phage concentration was
decreased, but plaques were never observed. HP1 would not
produce plaques in strain R3422. Thus, HP2 is restricted to its
original host, while HP1 will only infect Rd derivatives. Lyso-
gens of either phage, as well as the hybrid lysogens, were
immune to infection by their own phage. Furthermore, the
hybrid phage induced from strain R3403 had the same host
range, even though it contained the HP2 early promoter region
and immunity genes. Thus, the differences in plaquing between
HP1 and HP2 do not lie within the early control region. It is
possible that R2866 and its derivative, R3422, are inherently
resistant to lysis, including plaquing. Preliminary experiments
indicate that R2866 is more resistant to polymyxin-induced
lysis than strain Rd KW20 (data not shown).
Evidence for lysogenic conversion by HP2. While HP2 ap-
pears to infect the prophage-deleted mutant R3422, it was not
clear if it could lysogenize infections. To determine whether
HP2 was capable of lysogenic conversion of the strain with the
phage deleted, strain R3435 (the TSTE antibiotic cassette lo-
cated in the dam gene of the HP2 prophage) was created. The
dam gene encodes an adenine methylase that does not appear
necessary for growth, because this mutant prophage is still
methylated by the host’s methylase (data not shown). Phage
induced from R3435 was mixed with strains Rd, R3422, and
R2866 (Table 1) and plated on ribostamycin-containing choc-
olate agar. One hundred microliters of this supernatant con-
tained 	16,000 ribostamycin-conferring units when monitored
with strain R3422. Treatment of strain Rd with R3435 phage
did not generate any ribostamycin-resistant colonies; however,
treatment of strain R2866 generated 	160 ribostamycin-resis-
tant colonies. The same phenomenon similarly occurred when
marked HP1 or HP2 was mixed with ribostamycin-susceptible
lysogens. When the phage preparation was treated with
DNase, ribostamycin-resistant transformants were not ob-
tained, indicating that transformation was the most likely
mechanism of gene transfer. Transfer of ribostamycin resis-
tance via phage from R3435 to R3422 was relatively DNase
resistant compared to transfer to an HP2 lysogen. Further-
more, the transfer efficiency from R3435 was approximately
100-fold higher with transfer into strain R3422, which does not
have large regions of homology for the phage recombination.
FIG. 3. Early promoter comparison among HP1, HP2, and S2 type A. The numbers on either side of the sequences denote the nucleotide
positions of these loci in their respective phages. Large arrows delineate the promoter elements with the35 and10 sites in boldface and labeled.
Italic numbers denote the spacing between the 35 and 10 sites. Dashed lines indicate elements contained on the opposite strand. Rounded
boxes identify sequences consistent with the cI repressor binding sites, and the parallelograms indicate the cox repressor binding sites.
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FIG. 4. Sequence comparison of HP2 to HP1 and S2 type A. Similarity plots are measured as percent difference from the designated window
size. The dashed line represents the overall average similarity. Large peaks demonstrate the largest differences that are labeled with the HP2 gene
or region showing this difference. The scale under the genetic maps is in kilobases. (a) Complete chromosome comparison between HP1 and HP2.
Genetic maps are aligned to show differences in gene arrangement. A similarity plot scores the similarity over a 100-bp window. (b) Comparison
of the first 5.6 kb of S2 type A with HP2. The genetic maps of HP2 and S2 are identical in this region. This similarity plot was calculated over a
50-bp window.
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This suggests that HP2 is capable of lysogeny in addition to
lysis in strain R3422.
We would suspect phage infection to be much more efficient
than transformation. However, we have observed high trans-
formation rates (up to 104 CFU/g of DNA) with TSTE-
marked homologous DNA fragments into strain R2866. Scocca
has reported that the HP1 phage is extremely fragile (personal
communication), and we suspect this contributes to a large
amount of unpackaged phage DNA in these preparations that
is available for transformation.
Electron microscopy studies. Using a concentrated HP2 so-
lution, we used electron microscopy to determine the morphol-
ogy of HP2 (Fig. 6). As predicted from the sequence similar-
ities, HP2 is identical to HP1 by all visible measures. Its head
FIG. 5. Change in A600 (OD 600) after addition of mitomycin C. Mitomycin C was added when the culture reached an A600 of 0.15. Œ, R2866;
, R3422; , R3152; X, Rd; *, R3403.
TABLE 4. Plaquing assays with HP1, HP2 and mutant phagesa
Strain produc-
ing phage Phage pretreatment
Strain to be
plaqued
Plaquing strain
pretreatment Result
R2866 (HP2) R2866 Turbid lawn
R2866/R3404 R3422 Complete lysis, no growth
R2866/R3404 Diluted 1:100 R3422 Uniform incomplete lysis
R2866/R3404 Diluted 1:10,000 R3422 Turbid lawn
R2866/R3404 Rd Turbid lawn
R3152 (HP1) R3152 Turbid lawn
R3152/R3403 Rd Complete lysis, no growth
R3152/R3403 Diluted 1:100 Rd Uniform incomplete lysis
R3152/R3403 Diluted 1:10,000 Rd 1,000 plaques
R3152/R3403 R2866 Turbid lawn
R3152 Diluted 1:10,000, absorbed to Rd Rd Turbid lawn
R3152 Diluted 1:10,000, absorbed to R3422 Rd Turbid lawn
R2866 Absorbed to Rd R3422 Uniform incomplete lysis
R3152 Rd Preincubated with HP2 Turbid lawn
R2866 R3422 Preincubated with HP1 Turbid lawn
R3152 Diluted 1:10,000 Rd Preincubated with HP2 Turbid lawn
R3152 Diluted 1:10,000 Rd Preincubated with dam::TSTE HP2 Turbid lawn without antibiotic selection,
no growth with ribostamycin
R3152 Diluted 1:10,000 Rd Preincubated with HP2 diluted 1:100 1,000 turbid plaques
R3152 Diluted 1:10,000 Rd Preincubated with HP2 diluted 1:10,000 1,000 plaques
R3152 Diluted 1:10,000, absorbed to HP2
preabsorbed Rd culture
Rd Turbid lawn
R2866 Absorbed to HP1 preabsorbed
R3422 culture
R3422 Turbid lawn
a The first column describes the host of the phage used in the plaquing assay. When more than one strain is listed, phages from either strain gave the same result.
The second column describes any treatment the phage received prior to exposing it to the strain to be plaqued against in column 3. The fourth column describes any
treatment the strain to be plaqued received prior to exposure with the test phage in column 1.
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measures 50 
 4.5 nm in diameter, while its tails are 110 
 10
nm, which is approximately the size of the HP1 and S2 phages
(5). Some sheaths are found contracted, suggesting that an
injection mechanism is likely responsible for transferring the
phage chromosome into the bacterial host.
Promoter elements for structural genes. As in HP1, the
genes controlling structural elements appear to lack a sigma
70-like promoter, and very few intergenic regions exist in these
downstream genes. Of the intergenic regions, only the one
between orf16 and orf17 shows potential for a likely promoter
element. orf16 and orf15 are oriented oppositely from the
genes starting at orf17, and thus a pair of oppositely oriented
promoters is consistent with this organization. There is an
inverted repeat between orf15 and orf16 (Fig. 7), suggesting
that one regulator could bind both regions and drive both
transcripts equally. Presumably this regulator exists some-
FIG. 6. HP2 phage particle structure.
FIG. 7. orf31 amino acid sequence comparison. The amino acid sequences of orf31 of HP2 and HP1 are aligned as labeled. The middle line
depicts the similarity of the sequences from lines 1 and 3. Gray-shaded boxes show regions with high homology.
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where 3 to the orf2/cox gene in the pR-driven transcript. Con-
servation of regulatory elements and long transcripts is a com-
mon theme in bacteriophages (1).
In HP2, the promoter controlling expression of orf14 is iden-
tical to the one in HP1. In fact, orf14 shows 100% identity at
the protein level between the two phages. As in HP1, there do
not appear to be any cox- or cI-coded protein binding sites near
the orf14 promoter presumably putting it under control of an
alternative regulator: orf14 may be capable of transcription,
independent of the usual phage regulators.
Comparison to HP1 and S2. The HP2 phage appears to be
closely related to the HP1 phage (Fig. 4a). Its chromosome is
31.5 kb (1 kb smaller than that of HP1), and it does not contain
as many ORFs as HP1: 36 in HP2 compared to 41 in HP1. Of
the 41 HP1 ORFs, 35 are hypothetical based on the ORF
encoding a protein of 7 kDa and the presence of a potential
ribosomal binding site (9). According to the same criteria, the
HP2 chromosome contains 36 ORFs. The organization of the
first four ORFs suggests that HP2 is very closely related to the
S2 type A phage (Fig. 4b). As in S2, orf2, orf3, and orf4 of HP1
are missing in HP2: orf11 and orf12 of HP1 are also missing
from HP2. All of these small genes were contained in the early
regulatory region. The downstream sequence, believed to con-
tain the genes encoding phage structural elements, appears to
be highly conserved. The promoters and terminators of the
downstream transcripts are identical, as is the number of genes
compared to HP1. This mosaic pattern is typical when com-
paring closely related phages and suggests that divergence oc-
curs by recombination with each other, host DNA, and prob-
ably cryptic phages such as flu (25, 31, 36).
One area of the chromosome is unique to HP2: a small
portion of noncoding DNA, labeled as “intergenic” in Fig. 4a
and b. This 37-bp sequence is 92% identical to the DNA
encoding a portion of the gs60 antigen of Pasteurella haemo-
lytica (A. Mellors and R. C. Lo, unpublished observations
[GenBank accession no. U42028]). While this DNA does not
code for a product, it does suggest a possible lateral genetic
exchange. Lateral DNA transfer occurs from H. influenzae to
N. gonorrhoeae and Neisseria meningitidis (8, 23), and it seems
likely to occur between closely related genera like Haemophilus
and Pasteurella.
Restriction map of HP1, HP2, and S2. While the complete
sequence of the S2 phage is unknown, a restriction map of S2
types A, B, and C has been reported (28). Since the first 5.6 kb
of each of the S2 and HP2 sequences shows a great deal of
homology, it might be concluded that they are the same phage
in different hosts. A comparison of the limited restriction map
of HP1 and the S2 phages with that of HP2 is shown in Table
5: HP2 has a number of differences in comparison to HP1 and
to the three S2 subtypes. Since the restriction map of HP2 was
based on sequence and that of S2 was based on restriction
digests, some differences may be artifactual. Secondary struc-
ture may also conceal some restriction sites, and host modifi-
cation of the phage DNA may account for some differences,
because the restriction systems in R3152 and R2866 are likely
different.
Protein differences between HP1 and HP2. Table 6 com-
pares the levels of homology of the predicted protein products
between HP1 and HP2. The names of the ORFs of the H.
influenzae bacteriophages were derived from the original
HP1 designation by Esposito et al. (9). When the first 5.6 kb
of the S2 phage was sequenced, the ORFs were assigned
numbers that matched the HP1 designation, although they
were not consecutive. While most of the proteins show a large
degree of similarity, there are several striking differences: the
orf10(HP2), orf21(HP2) and orf22(HP2) proteins are encoded
by genes with no homology with any known DNA sequence in
the National Center for Biotechnology Information database.
While there are differences in sequence, the amino acid simi-
larity scores of these proteins in HP1 in comparison to HP2
suggest conservation of function.
(i) orf10(HP2). Bacteriophage S2 has orf1 and -2, which are
unique to S2, but the next hypothetical ORF is orf5, since it is
identical to orf5 of HP1. S2 lacks the third and fourth ORFs
found in HP1; hence there is no orf3 or orf4 in S2. A similar
situation arises in HP2. The gene following rep in HP2 is not
TABLE 5. Restriction fragment sizes from the HP1/S2 family
of bacteriophages
Restriction
fragment
Fragment size (kb) ina:
HP1 HP2 S2A S2B S2C
BamHI 26.3 31.5 26.3 26.3 26.3
6.0 5.3 5.3 6.1
BglI 17.6 17.9 10.1 17.6 17.6
6.2 6.6 7.5 4.8 6.1
5.0 3.2 4.8 3.0 4.8
2.4 2.6 3.0 2.6 2.35
0.89 0.94 2.6 2.4 0.85
0.28 0.28 2.4 0.85 0.35
0.85 0.35
0.35
BglII 10.5 9.6 10.0 10.0 10.8
9.6 9.3 9.6 9.6 9.6
6.9 6.2 6.2 7.1 7.1
5.2 6.1 5.9 5.0 5.0
0.11 0.11 0.12 0.12 0.12
EcoRI 17.8 12.9 18.6 17.8 17.8
12.9 10.5 12.7 12.2 12.9
1.6 8.1 1.7 1.7
HaeIII 6.7 8.3 6.75 6.75 6.75
5.5 6.2 6.0 5.3 5.6
3.9 3.9 5.3 3.8 3.8
3.8 3.8 3.8 3.7 3.75
3.5 3.0 3.7 3.45 2.45
2.5 2.8 1.8 2.45 2.45
2.4 1.0 1.1 1.8 2.35
1.0 1.0 1.0 1.1 1.1
1.0 0.86 0.95 1.0 1.0
0.97 0.32 0.90 0.95 0.95
0.86 0.07 0.2 0.90 0.9
0.18 0.2 0.2
0.05
MspI 19.0 14.7 29.0 29.0 32.4
13.4 11.3 2.45 2.45
2.29
0.40
0.34
a The fragment sizes of HP1 and HP2 were calculated with sites determined by
sequence rather than actual restriction cuts. We have verified the locations of the
BamHI, BglII, and EcoRI sites in HP2 (data not shown).
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identical to orf10 of HP1 (Fig. 4a). Although the inferred gene
product shares the same N terminus, a distinct sequence of 270
bp makes up the rest of the 309-bp ORF. Thus, the gene in
HP2 is identified as orf10(HP2) to distinguish it from the same
region in HP1. Since we were unable to obtain an S2 lysogen,
it is unclear whether this gene is unique to HP2. orf10(HP2) is
also found in invasive lysogens closely related to R2866 (un-
published observations), so it is not likely to be a spurious
finding. Since this phage appears to function without the HP1
equivalents of orf11 and orf12, these genes may not be neces-
sary for phage function. This suggests that HP2 may have lost
these nonessential genes in its evolution from HP1. The pro-
tein encoded by orf10(HP2) has weak homology to that coded
for by orf10 of HP1 (37% identity, 61% similarity) and may
serve a similar purpose.
(ii) Lytic transcript differences. Downstream of orf10(HP2),
the nucleotide sequence of HP2 is similar to that of HP1. One
large difference occurs between bases 15992 and 17307, includ-
ing orf21 and orf22 (Fig. 4a). This region has no known match
at the nucleotide level in GenBank. However, the putative
products of these genes each share 64% similarity and 42%
identity (respectively) in spite of the large difference in nucle-
otide sequence. This suggests that the function of these gene
products is conserved. As with most of the genes in this tran-
script, a function is not known or suggested by motif searches.
orf22 was implicated as the location of the ts2 mutation in HP1
that produces a tailless phage (14). If orf22 is involved in some
aspect of tail biosynthesis, our data suggest that the tail struc-
tures may be different between HP1 and HP2.
HP2 orf27 also differs from HP1 (Fig. 4a). A change in the
nucleotide sequence yields a mosaic with a nearly identical N
terminus and a divergent C terminus compared to those of
HP1. The last 50 amino acids of the orf27(HP2) gene product
are identical to those of orf27 of HP1. This suggests a con-
TABLE 6. Comparison of the HP2 ORFs to those of HP1 and S2
Genea
Positionb Protein
identity/similarityc Predicted functionHP2 HP1
Integrase 702–1712 698–1711 97/97, 98/98 Integrates phage into host chromosome
to establish lysogeny
orf1(S) 1715–2476 1698–2315 0/0, 100/100 ?
cI 2671–3243 3061–3636 96/97, 95/97 Maintains lysogeny by repressing pR
promoters
orf2(S) cox 3311–3571 3574–3993 39/59, 100/100 Inhibits action of cI and competes with
integrase (acts as excisionase)
orf5 3710–4210 4050–4553 93/94, 100/100 ?
orf6 4232–4597 4572–4940 98/98, 99/99 ?
orf7 4600–4782 4940–5125 100/100, 100/100 ?
orf8 4797–5075 5137–5418 100/100, 100/100 ?
orf9 5129–5386 5469–5729 100/100, 100/100 ?
rep 5338–7716 5732–8059 98/98 Phage DNA polymerase
orf10(HP2) 7731–8031 8071–8370 37/61 ?
dam 8052–8567 9169–9687 98/98 Dam methylase
orf14 8871–9269 9989–10390 100/100 ?
orf15 96411–10675 10575–11794 97/98 Portal
orf16 10668–12488 11784–13607 96/97 Terminase
orf17 12692–13582 13826–14722 91/93 Scaffold
orf18 13588–14595 14726–15736 96/97 Capsid
orf19 14618–15454 15750–16595 96/97 Packaging
orf20 15450–15899 16588–17040 90/94 Packaging
orf21(HP2) 15890–16372 17028–17528 67/79 ?
orf22(HP2) 16323–17057 17506–18189 42/61 ?
orf23 17332–18459 18204–19334 99/99 Tail sheath
orf24 18489–18915 19338–19790 100/100 Tail tube
hol 18987–19238 19877–20113 98/98 Holin
lys 19255–19791 20106–20666 95/96 Lysis
orf25 19799–20123 20651–20998 98/99 ?
orf26 20319–20624 21185–21493 100/100 ?
orf27 20816–22942 21682–23751 73/81 ?
orf28 22949–23281 23755–24090 98/99 ?
orf29 23398–24443 24083–25264 98/99 ?
orf30 24456–24980 25261–25785 100/100 ?
orf31 25007–27736 25815–28592 78/86 Tail fibers
orf32 27751–28380 28604–29206 91/96 Tail collar
orf33 28396–29160 29239–30015 97/98 ?
orf34 29150–29707 30002–30565 94/96 ?
orf35 29711–31309 30562–32163 96/98 ?
a ORFs with names not beginning in “orf” have experimental functions. Gene names that include “(S)” designate a gene novel to S2 which is also found in HP2. Gene
names that include “(HP2)” designate a gene novel to HP2 and that has not been described in either HP1 or S2.
b The position numbers refer to the nucleotides composing the start-to-stop codons beginning with the first nucleotide of the phage chromosome as it is packaged
in the bacteriophage head.
c Identity/similarity scores refer to the score of amino acid identity or similarity of the given ORF with scores of HP2 versus HP and HP2 versus S2 listed in italics.
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served function for the N terminus of this protein. As in orf21
and orf22, it could also be hypothesized that differences in
orf27 account for some of the phenotypic differences with re-
gard to plaquing and lysogenization.
There are two changes in the sequence of HP2 orf31 in
comparison to that of HP1 (Fig. 7). Based on homology to P2
and phage 186, orf31 is thought to encode the tail fibers of the
bacteriophage (9). While the protein product of orf31(HP2) is
nearly identical to that of orf31 in HP1 for the N-terminal 360
amino acids, the sequence of amino acids 361 to 440 is unique
and not highly conserved. This region is followed by near-
complete identity until HP2 position 606, where there are
some conserved changes until residue 638. There is only mod-
est conservation of the 79 amino acids at the C terminus. If this
ORF encodes the tail fibers, it is highly suggestive of an altered
binding motif at the C terminus that may allow HP2 to distin-
guish its host from other H. influenzae strains. The variation
across the middle of this ORF may alter the three-dimensional
structure of the tail fiber or allow it to be presented to the host
surface in a slightly different orientation.
Our data suggest that HP2 represents a variant of HP1 that
diverged before S2 had evolved to its current structure. In this
scenario, HP2 acquired features of S2 before it evolved to its
current state of differentiation from HP1. This evolution is
supported by a decrease in the number of genes in HP2 and S2
in comparison to the number in HP1. Bacteriophages evolve to
efficiency, and losing unnecessary genes is more likely than
gaining extra small genes. The loss of the pR1 promoter sup-
ports this contention. Evidence from Esposito et al. suggests
that pR2 functions as well as pR1, thus negating a need for two
promoters at such close proximity (10). cI and cox binding
experiments suggest that both pR1 and pR2 are regulated by
the same elements. The S2 promoter lacks pR1, suggesting it is
not necessary. HP2 contains pR1, but in a configuration that
may be less active than the HP1 version (16 bp between the
10 and 35 regions rather than the ideal 17-bp configura-
tion). This comparison places HP2 between HP1 and S2 in the
evolving loss of pR1.
Uptake elements. hUSs consist of a 9-bp core sequence and
occur in the Rd KW20 genome, on average, once every 1,249
bp (38). The ability of the H. influenzae phage DNA to be
introduced by transformation suggests that the phage genomes
would have many hUSs. As an alternative to transfection,
transformation could serve as a means for phage DNA dissem-
ination in H. influenzae, and transformation bypasses restric-
tion-modification surveillance, unlike bacteriophage infection
(42). The HP1 genome contains only 17 hUSs, an average
density lower (0.53/kb) than that of the Rd KW20 genome in
general (0.81/kb) (9). HP2 also has 17 hUSs, although at dif-
ferent locations from HP1. We have found that bacteriophage
DNA containing a kanamycin resistance cassette transforms
with frequencies equivalent to those of chromosomal DNA
(containing antibiotic resistance markers) into competent
strain Rd KW20 (unpublished observation).
Attachment sites. The integration site for HP1 and S2 is the
stem-loop of the gene encoding tRNALeu (18, 20, 35). The attP
target for HP2 is the same (data not shown). The anticodon
stem-loop of the tRNALeu is in the middle of an operon en-
coding tRNALys, tRNALeu, and tRNAGly. As in HP1 and S2,
the attP site in HP2 carries duplication of these genes to main-
tain transcription into functional tRNA molecules. More than
one chromosomal attachment site has been described in strain
Rd KW20 based on the presence of phage DNA in different
SmaI fragments of chromosomal DNA (22). Since the SmaI
restriction fragment patterns determined by pulsed-field gel
electrophoresis differ between Rd KW20 and strain R2866,
comparing the usage of these alternate attachment sites by
HP2 is not possible.
We conclude that HP2 is closely related to HP1 but has a
different host: unencapsulated H. influenzae.
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